The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Self-citationMutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
McDonald-McGinn, D. M., Sullivan, K. E., Marino, B., Philip, N., Swillen, A., Vorstman, J. A. S., Zackai, E. H., Emanuel, B. S., Vermeesch, J. R., Morrow, B. E., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.71 · Cited by 2,236
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Jones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Bäcklund, L. M., Ichimura, K., & Collins, V. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2097 · Cited by 944
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Pfister, S., Janzarik, W. G., Remke, M., Ernst, A., Werft, W., Becker, N., Toedt, G., Wittmann, A., Kratz, C., Olbrich, H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33656 · Cited by 523
Self-citationTargeting the RAF–MEK–ERK pathway in cancer therapy
Montagut, C., & Settleman, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.022 · Cited by 468
Yang, H., Higgins, B., Kolinsky, K., Packman, K., Go, Z., Iyer, R., Kolis, S., Zhao, S., Lee, R., Grippo, J. F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0646 · Cited by 407
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
Tannapfel, A., Sommerer, F., Benicke, M., Katalinic, A., Uhlmann, D., Witzigmann, H., Hauss, J., & Wittekind, C. (2003) · Gut · doi:10.1136/gut.52.5.706 · Cited by 343
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Dougherty, M. J., Santi, M., Brose, M. S., Ma, C., Resnick, A. C., Sievert, A. J., Storm, P. B., & Biegel, J. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq007 · Cited by 324
Jones, D. T. W., Kocialkowski, S., Liu, L., Pearson, D. M., Ichimura, K., & Collins, V. P. (2009) · Oncogene · doi:10.1038/onc.2009.73 · Cited by 321
Forshew, T., Tatevossian, R. G., Lawson, A. R., Ma, J., Neale, G., Ogunkolade, B. W., Jones, T. A., Aarum, J., Dalton, J., Bailey, S., et al. (2009) · The Journal of Pathology · doi:10.1002/path.2558 · Cited by 304
Korshunov, A., Meyer, J., Capper, D., Christians, A., Remke, M., Witt, H., Pfister, S., von Deimling, A., & Hartmann, C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0550-z · Cited by 279
Self-citationBRAFE600 in benign and malignant human tumours
Michaloglou, C., Vredeveld, L. C. W., Mooi, W. J., & Peeper, D. S. (2008) · Oncogene · doi:10.1038/sj.onc.1210704 · Cited by 275
Schiffman, J. D., Hodgson, J. G., VandenBerg, S. R., Flaherty, P., Polley, M.-Y. C., Yu, M., Fisher, P. G., Rowitch, D. H., Ford, J. M., Berger, M. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1851 · Cited by 251
Jacob, K., Albrecht, S., Sollier, C., Faury, D., Sader, E., Montpetit, A., Serre, D., Hauser, P., Garami, M., Bognar, L., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605179 · Cited by 186
Hoeflich, K. P., Herter, S., Tien, J., Wong, L., Berry, L., Chan, J., O'Brien, C., Modrusan, Z., Seshagiri, S., Lackner, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3563 · Cited by 174
Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas
Knobbe-Thomsen, C. B., REIFENBERGER, J., & Reifenberger, G. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0929-9 · Cited by 156
Self-citationHorbinski, C., Hamilton, R. L., Nikiforov, Y. E., & Pollack, I. F. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0634-9 · Cited by 153
Perry, A., Giannini, C., Scheithauer, B. W., Rojiani, A. M., Yachnis, A. T., Seo, &. S., Johnson, P. C., Kho, J., & Shapiro, S. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199707000-00004 · Cited by 136
Weber, R. G., Hoischen, A., Ehrler, M., Zipper, P., Kaulich, K., Blaschke, B., Becker, A. J., Weber‐Mangal, S., Jauch, A. T., Radlwimmer, B., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209851 · Cited by 118
Self-citationAlterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma
Yu, J., Deshmukh, H., Gutmann, R. J., Emnett, R. J., Rodríguez, F. J., Watson, M. A., Nagarajan, R., & Gutmann, D. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c0664a · Cited by 111
Jeuken, J. W. M., den Broecke, C. V., Gijsen, S. J., Boots‐Sprenger, S., & Wesseling, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0239-0 · Cited by 111
Self-citationActivated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation
Robinson, J. P., VanBrocklin, M. W., Guilbeault, A. R., Signorelli, D. L., Brandner, S., & Holmen, S. L. (2009) · Oncogene · doi:10.1038/onc.2009.333 · Cited by 99
Mutation analysis of B-RAF gene in human gliomas
Basto, D., Trovisco, V., Lopes, J. M., Martins, A. M., Pardal, F., Soares, P., & Reis, R. M. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0936-x · Cited by 90
Functional characterization of a BRAF insertion mutant associated with pilocytic astrocytoma
Eisenhardt, A. E., Olbrich, H., Röring, M., Janzarik, W. G., Anh, T. N. V., Cin, H., Remke, M., Witt, H., Korshunov, A., Pfister, S. M., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25893 · Cited by 88
Self-citationPleomorphic Xanthoastrocytoma as a Component of a Cerebellar Ganglioglioma
Lindboe, C. F., Cappelen, J., & Kepes, J. J. (1992) · Neurosurgery · doi:10.1227/00006123-199208000-00023 · Cited by 86
Kordek, R., Biernat, W., Sapieja, W., Alwasiak, J., & Liberski, P. P. (1995) · Acta Neuropathologica · doi:10.1007/bf00296366 · Cited by 45
Pleomorphic Xanthoastrocytoma with Gangliogliomatous Component
Vajtai, I., Varga, Z., & Aguzzi, A. (1997) · Pathology - Research and Practice · doi:10.1016/s0344-0338(97)80039-8 · Cited by 35
Pleomorphic xanthoastrocytoma as a component of a temporal lobe cystic ganglioglioma: a case report
Sugita, Y., Irie, K., Ohshima, K., Hitotsumatsu, T., Satō, O., & Arimura, K. (2009) · Brain Tumor Pathology · doi:10.1007/s10014-009-0244-1 · Cited by 30
RAF expression in human astrocytic tumors
Hagemann (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000097 · Cited by 30
Murray, J. C., Donahue, D. J., Malik, S. I., Dzurik, Y., Braly, E. Z., Dougherty, M. J., Eaton, K. W., & Biegel, J. A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0350-2 · Cited by 21
Resequencing Analysis of the Human Tyrosine Kinase Gene Family in Pancreatic Cancer
Kubo, T., Kuroda, Y., Kokubu, A., Hosoda, F., Arai, Y., Hiraoka, N., Hirohashi, S., & Shibata, T. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181b8feb0 · Cited by 20
Cited by
Weller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., Nishikawa, R., Rosenthal, M., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,124
Self-citationTargeting the MAPK–RAS–RAF signaling pathway in cancer therapy
Santarpia, L., Lippman, S. M., & El-Naggar, A. K. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.645805 · Cited by 1,027
Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas
the St. Jude Children's Research Hospital–Washington University Pediatric Cancer Genome Project (2013) · Nature Genetics · doi:10.1038/ng.2611 · Cited by 835
Vemurafenib: the first drug approved for BRAF-mutant cancer
Bollag, G., Tsai, J., Zhang, J., Zhang, C., Ibrahim, P., Nolop, K., & Hirth, P. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3847 · Cited by 822
Glioma Subclassifications and Their Clinical Significance
Chen, R., Smith-Cohn, M., Cohen, A. L., & Colman, H. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0519-x · Cited by 812
Metadata
- Authors
- Schindler, G., Capper, D., Meyer, J., Janzarik, W., Omran, H., Herold-Mende, C., Schmieder, K., Wesseling, P., Mawrin, C., Hasselblatt, M., Louis, D. N., Korshunov, A., Pfister, S., Hartmann, C., Paulus, W., Reifenberger, G., & von Deimling, A.
- Venue
- Acta Neuropathologica
- Published
- 2011-01-29
- Volume
- 121
- Issue
- 3
- Pages
- 397-405
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2146267855
- Cited by
- 1,034
- References
- 35
- FWCI
- 32.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.